Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ants Toi

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
BJU International|April 22, 2011
Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohortGreg Trottier, Monique J Roobol, Nathan Lawrentschuk, et al.
American Journal of Medical Genetics. Part A|May 17, 2007
The PDAC syndrome (pulmonary hypoplasia/agenesis, diaphragmatic hernia/eventration, anophthalmia/microphthalmia, and cardiac defect) (Spear syndrome, Matthew-Wood syndrome): report of eight cases including a living child and further evidence for autosomal recessive inheritanceDavid Chitayat, Hana Sroka, Sarah Keating, et al.
Radiology|May 18, 2007
Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbideMasoom A Haider, Sean R H Davidson, Ashwini V Kale, et al.
Cancer Gene Therapy|September 23, 2003
A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancerSuzane Trudel, John Trachtenberg, Ants Toi, et al.
The Journal of Urology|September 24, 2020
Reply by AuthorsDominik Deniffel, Emmanuel Salinas, Marc Ientilucci, et al.
European Urology|January 8, 2011
Impact of 5α-reductase inhibitors on men followed by active surveillance for prostate cancerAntonio Finelli, Greg Trottier, Nathan Lawrentschuk, et al.
Urologic Oncology|August 8, 2017
Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicionBimal Bhindi, Haiyan Jiang, Cedric Poyet, et al.
Radiology|May 25, 2021
Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate CancerDominik Deniffel, Gerard M Healy, Xin Dong, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 1, 2020
Utility of digital rectal examination in a population with prostate cancer treated with active surveillanceJaime O Herrera-Caceres, Marian S Wettstein, Hanan Goldberg, et al.
Urology|December 3, 2014
The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsyBimal Bhindi, David Margel, Robert J Hamilton, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
BJU International|April 22, 2011
Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohortGreg Trottier, Monique J Roobol, Nathan Lawrentschuk, et al.
American Journal of Medical Genetics. Part A|May 17, 2007
The PDAC syndrome (pulmonary hypoplasia/agenesis, diaphragmatic hernia/eventration, anophthalmia/microphthalmia, and cardiac defect) (Spear syndrome, Matthew-Wood syndrome): report of eight cases including a living child and further evidence for autosomal recessive inheritanceDavid Chitayat, Hana Sroka, Sarah Keating, et al.
Radiology|May 18, 2007
Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbideMasoom A Haider, Sean R H Davidson, Ashwini V Kale, et al.
Cancer Gene Therapy|September 23, 2003
A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancerSuzane Trudel, John Trachtenberg, Ants Toi, et al.
The Journal of Urology|September 24, 2020
Reply by AuthorsDominik Deniffel, Emmanuel Salinas, Marc Ientilucci, et al.
European Urology|January 8, 2011
Impact of 5α-reductase inhibitors on men followed by active surveillance for prostate cancerAntonio Finelli, Greg Trottier, Nathan Lawrentschuk, et al.
Urologic Oncology|August 8, 2017
Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicionBimal Bhindi, Haiyan Jiang, Cedric Poyet, et al.
Radiology|May 25, 2021
Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate CancerDominik Deniffel, Gerard M Healy, Xin Dong, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 1, 2020
Utility of digital rectal examination in a population with prostate cancer treated with active surveillanceJaime O Herrera-Caceres, Marian S Wettstein, Hanan Goldberg, et al.
Urology|December 3, 2014
The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsyBimal Bhindi, David Margel, Robert J Hamilton, et al.
Pageof 11